NCT03503149View on ClinicalTrials.gov

Molecular Tumor Board at the Center for Personalized Medicine Tübingen

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2028

Conditions

Advanced Cancer

Interventions

OTHER

no intervention

observational study

Trial Locations (1)

72076

RECRUITING

University Hospital Tübingen, Tübingen

All Listed Sponsors

lead

University Hospital Tuebingen

OTHER